Interaction between the BDNF gene Val/66/Met polymorphism and morning cortisol levels as a predictor of depression in adult women

British Journal of Psychiatry

Volumn 201, Issue 4, 2012, Pages 313-319

  Herbert, J ^a   Ban, M ^b   Brown, G W ^c   Harris, T O ^c   Ogilvie, A ^d   Uher, R ^c,e   Craig, T K J ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DNA; HYDROCORTISONE;

ADULT; ADULT DISEASE; ARTICLE; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; PREMENOPAUSE; QUESTIONNAIRE; SALIVA LEVEL;

ADULT; ANXIETY; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYDROCORTISONE; LIFE CHANGE EVENTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; SALIVA;

EID: 84866996041     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.111.107037     Document Type: Article

References (54)

1. Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006; 59: 1116-27.
2. D'Sa C, Duman RS. Antidepressants and neuroplasticity. Bipolar Disord 2002; 4: 183-94. (Pubitemid 34591244)
3. Garcia R. Stress, metaplasticity, and antidepressants. Curr Mol Med 2002; 2: 629-38. (Pubitemid 35256294)
4. Alme MN, Wibrand K, Dagestad G, Bramham CR. Chronic fluoxetine treatment induces brain region-specific upregulation of genes associated with BDNF-induced long-term potentiation. Neural Plast 2007; 2007: 264-96.
5. De Foubert G, Carney SL, Robinson CS, Destexhe EJ, Tomlinson R, Hicks CA, et al. Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment. Neuroscience 2004; 128: 597-604. (Pubitemid 39277429)
6. Pinnock SB, Lazic SE, Wong HT, Wong IH, Herbert J. Synergistic effects of dehydroepiandrosterone and fluoxetine on proliferation of progenitor cells in the dentate gyrus of the adult male rat. Neuroscience 2009; 158: 1644-51.
7. Rantamaki T, Hendolin P, Kankaanpaa A, Mijatovic J, Piepponen P, Domenici E, et al. Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain. Neuropsychopharmacology 2007; 32: 2152-62. (Pubitemid 47417694)
8. Schmidt HD, Duman RS. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol 2007; 18: 391-418. (Pubitemid 47356367)
9. Pinnock SB, Blake AM, Platt NJ, Herbert J. The roles of BDNF, pCREB and Wnt3a in the latent period preceding activation of progenitor cell mitosis in the adult dentate gyrus by fluoxetine. PLoS One 2010; 5: e13652.
10. Pinnock SB, Herbert J. Brain-derived neurotropic factor and neurogenesis in the adult rat dentate gyrus: interactions with corticosterone. Eur J Neurosci 2008; 27: 2493-500. (Pubitemid 351781685)
11. Malberg JE, Duman RS. Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology 2003; 28: 1562-71. (Pubitemid 41070856)
12. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000; 20: 9104-10. (Pubitemid 32042912)
13. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002; 109: 143-8. (Pubitemid 34258493)
14. Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 2005; 57: 1068-72. (Pubitemid 40613035)
15. Lee BH, Kim H, Park SH, Kim YK. Decreased plasma BDNF level in depressive patients. J Affect Disord 2007; 101: 239-44. (Pubitemid 46879923)
16. Chen ZY, Patel PD, Sant G, Meng CX, Teng KK, Hempstead BL, et al. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 2004; 24: 4401-11. (Pubitemid 38608151)
17. Schumacher J, Jamra RA, Becker T, Ohlraun S, Klopp N, Binder EB, et al. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry 2005; 58: 307-14. (Pubitemid 41133624)
18. Levinson DF. The genetics of depression: a review. Biol Psychiatry 2006; 60: 84-92.
19. Hong CJ, Huo SJ, Yen FC, Tung CL, Pan GM, Tsai SJ. Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology 2003; 48: 186-9.
20. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 301: 386-9. (Pubitemid 36877077)
21. Bukh JD, Bock C, Vinberg M, Werge T, Gether U, Kessing LV. No interactions between genetic polymorphisms and stressful life events on outcome of antidepressant treatment. European Neuropsychopharmacol 2010; 20: 327-35.
22. Karg K, Burmeister M, Shedden K, Sen S. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry 2011; 68: 444-54.
23. Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Kim YH, et al. Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders. Biol Psychiatry 2007; 62: 423-8. (Pubitemid 47284032)
24. Uher R, McGuffin P. The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update. Mol Psychiatry 2010; 15: 18-22.
25. Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Kim YH, et al. BDNF genotype potentially modifying the association between incident stroke and depression. Neurobiol Aging 2008; 29: 789-92. (Pubitemid 351400826)
26. Bukh JD, Bock C, Vinberg M, Werge T, Gether U, Vedel Kessing L. Interaction between genetic polymorphisms and stressful life events in first episode depression. J Affect Disord 2009; 119: 107-15.
27. Kaufman J, Yang BZ, Douglas-Palumberi H, Grasso D, Lipschitz D, Houshyar S, et al. Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry 2006; 59: 673-80.
28. Carver CS, Johnson SL, Joormann J, Lemoult J, Cuccaro ML. Childhood adversity interacts separately with 5-HTTLPR and BDNF to predict lifetime depression diagnosis. J Affect Disord 2011; 132: 89-93.
29. Aguilera M, Arias B, Wichers M, Barrantes-Vidal N, Moya J, Villa H, et al. Early adversity and 5-HTT/BDNF genes: new evidence of gene-environment interactions on depressive symptoms in a general population. Psychol Med 2009; 39 : 1425-32.
30. Sachar EJ, Hellman L, Roffwarg HP, Halpern FS, Fukushima DK, Gallagher TF. Disrupted 24-hour patterns of cortisol secretion in psychotic depression. Arch Gen Psychiatry 1973; 28: 19-24.
31. Carroll BJ. Use of the dexamethasone suppression test in depression. J Clin Psychiatry 1982; 43: 44-50. (Pubitemid 13208348)
32. Rush AJ, Giles DE, Schlesser MA, Orsulak PJ, Parker Jr CR, Weissenburger JE, et al. The dexamethasone suppression test in patients with mood disorders. J Clin Psychiatry 1996; 57: 470-84. (Pubitemid 26362312)
33. Harris TO, Borsanyi S, Messari S, Stanford K, Brown GW, Cleary SE, et al. Morning cortisol as a risk factor for subsequent major depressive disorder in adult women. Br J Psychiatry 2000; 177: 505-10. (Pubitemid 32005480)
34. Goodyer IM, Tamplin A, Herbert J, Altham PM. Recent life events, cortisol, dehydroepiandrosterone and the onset of major depression in high-risk adolescents. Br J Psychiatry 2000; 177: 499-504. (Pubitemid 32005479)
35. Goodyer IM, Croudace T, Dudbridge F, Ban M, Herbert J. Polymorphisms in BDNF (Val66Met) and 5-HTTLPR, morning cortisol and subsequent depression in at-risk adolescents. Br J Psychiatry 2010; 197: 365-71.
36. Wing JK, Barbor T, Brugha TS. SCAN: schedule for clinical assessment in neuropsychiatry. Arch Gen Psychiatry 1990; 47: 589-93. (Pubitemid 20189971)
37. Brown GW, Bifulco A, Harris T, Bridge L. Life stress, chronic subclinical symptoms and vulnerability to clinical depression. J Affect Disord 1986; 11: 1-19. (Pubitemid 16045970)
38. Brown GW, Andrews B, Harris T, Adler Z, Bridge L. Social support, selfesteem and depression. Psychol Med 1986; 16: 813-31.
39. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA, 1994.
40. Finlay-Jones R, Brown GW, Duncan-Jones P, Harris T, Murphy E, Prudo R. Depression and anxiety in the community: replicating the diagnosis of a case. Psychol Med 1980; 10: 445-54. (Pubitemid 11140134)
41. Andrews B, Brown GW. Self Evaluation and Social Support (SESS) Manual. Royal Holloway College, 1991.
42. Brown GW, Harris TO. Social Origins of Depression: A Study of Psychiatric Disorder in Women. Tavistock Publications, 1978.
43. Brown GW, Harris TO. Life Events & Illness . Guilford Press, 1989.
44. Brown GW, Bifulco A, Harris TO. Life events, vulnerability and onset of depression: some refinements. Br J Psychiatry 1987; 150: 30-42. (Pubitemid 17081815)
45. Nepomnaschy PA, Altman RM, Watterson R, Co C, McConnell DS, England BG. Is cortisol excretion independent of menstrual cycle day? A longitudinal evaluation of first morning urinary specimens. PLoS One 2011; 6: e18242.
46. Rothman KJ, Greenland RW, Lash TL. Modern Epidemiology. Lippincott Williams & Wilkins, 2008.
47. Young AH, Gallagher P, Porter RJ. Elevation of the cortisol- dehydroepiandrosterone ratio in drug-free depressed patients. Am J Psychiatry 2002; 159: 1237-9. (Pubitemid 34743270)
48. Kendler KS, Thornton LM, Gardner CO. Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression. Am J Psychiatry 2001; 158: 582-6. (Pubitemid 32289820)
49. Homberg JR, Lesch KP. Looking on the bright side of serotonin transporter gene variation. Biol Psychiatry 2011; 69: 513-9.
50. Pinnock SB, Balendra R, Chan M, Hunt LT, Turner-Stokes T, Herbert J. Interactions between nitric oxide and corticosterone in the regulation of progenitor cell proliferation in the dentate gyrus of the adult rat. Neuropsychopharmacology 2007; 32: 493-504. (Pubitemid 46106955)
51. Huang GJ, Herbert J. Stimulation of neurogenesis in the hippocampus of the adult rat by fluoxetine requires rhythmic change in corticosterone. Biol Psychiatry 2006; 59: 619-24. (Pubitemid 43357956)
52. Frodl T, Reinhold E, Koutsouleris N, Reiser M, Meisenzahl EM. Interaction of childhood stress with hippocampus and prefrontal cortex volume reduction in major depression. J Psychiatr Res 2010; 44: 799-807.
53. Castren E, Rantamaki T. Neurotrophins in depression and antidepressant effects. Novartis Found Symp 2008; 289: 43-52; discussion 3-9, 87-93.
54. Maya Vetencourt JF, Sale A, Viegi A, Baroncelli L, De Pasquale R, O'Leary OF, et al. The antidepressant fluoxetine restores plasticity in the adult visual cortex. Science 2008; 320: 385-8. (Pubitemid 351555663)